- Home
- EUDA vs LXRX Comparison
EUDA vs LXRX Comparison
Compare EUDA & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EUDA
- LXRX
- Stock Information
- Founded
- EUDA 2021
- LXRX 1995
- Country
- EUDA Singapore
- LXRX United States
- Employees
- EUDA N/A
- LXRX N/A
- Industry
- EUDA Blank Checks
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- EUDA Finance
- LXRX Health Care
- Exchange
- EUDA Nasdaq
- LXRX Nasdaq
- Market Cap
- EUDA 139.3M
- LXRX 124.4M
- IPO Year
- EUDA N/A
- LXRX 2000
- Fundamental
- Price
- EUDA $3.71
- LXRX $0.50
- Analyst Decision
- EUDA
- LXRX Buy
- Analyst Count
- EUDA 0
- LXRX 4
- Target Price
- EUDA N/A
- LXRX $3.67
- AVG Volume (30 Days)
- EUDA 105.8K
- LXRX 31.4M
- Earning Date
- EUDA 01-01-0001
- LXRX 03-06-2025
- Dividend Yield
- EUDA N/A
- LXRX N/A
- EPS Growth
- EUDA N/A
- LXRX N/A
- EPS
- EUDA N/A
- LXRX N/A
- Revenue
- EUDA $3,811,496.00
- LXRX $31,081,000.00
- Revenue This Year
- EUDA $66.63
- LXRX N/A
- Revenue Next Year
- EUDA $119.95
- LXRX $101.91
- P/E Ratio
- EUDA N/A
- LXRX N/A
- Revenue Growth
- EUDA N/A
- LXRX 2481.48
- 52 Week Low
- EUDA $1.64
- LXRX $0.28
- 52 Week High
- EUDA $6.30
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- EUDA 44.94
- LXRX 53.54
- Support Level
- EUDA $3.59
- LXRX $0.32
- Resistance Level
- EUDA $4.04
- LXRX $0.71
- Average True Range (ATR)
- EUDA 0.21
- LXRX 0.06
- MACD
- EUDA -0.02
- LXRX 0.03
- Stochastic Oscillator
- EUDA 18.75
- LXRX 46.95
About EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a Singapore-based health technology company that operates a first-of-its-kind Southeast Asian digital healthcare ecosystem aimed at making healthcare affordable and accessible, The company's proprietary unified AI platform quickly assesses a patient's medical history, triages a condition, digitally connects patients with clinicians, and predicts optimal treatment outcomes. The company caters to all stages of care, including wellness and prevention, urgent care and emergencies, pre-existing conditions, and aftercare services. The company operates in two segments namely Medical services and property management services, out of which the company derives its maximum revenue from Medical services.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.